Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | FAAH | O00519 | 2/20 | 0.42 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | CASP3 | P42574 | 1/20 | 0.41 |
| ▸ | CASP7 | P55210 | 1/20 | 0.41 |
| ▸ | BCHE | P06276 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8537851 | 0.75 | NAAA (0.48) | NAAAHPGDSMN1; SMN2FKBP1ANPC1 | |
| SCHEMBL7296671 | 0.75 | NAAA (0.48) | NAAAHPGDSMN1; SMN2FKBP1ANPC1 | |
| SCHEMBL7009036 | 0.74 | KMT2A (0.46) | HPGDSMN1; SMN2ALDH1A1POLBACHE | |
| SCHEMBL8070471 | 0.74 | NAAA (0.47) | NAAAHPGDSMN1; SMN2FKBP1ANPC1 | |
| SCHEMBL8960581 | 0.72 | NAAA (0.48) | NAAAHPGDSMN1; SMN2FKBP1ANPC1 | |
| SCHEMBL16592848 | 0.72 | FAAH (0.43) | NAAASMN1; SMN2NPC1TDP1FAAH | |
| SCHEMBL14421594 | 0.71 | TSHR (0.40) | NAAATDP1ALDH1A1POLBL3MBTL1 | |
| SCHEMBL14421595 | 0.71 | TSHR (0.40) | NAAATDP1ALDH1A1POLBL3MBTL1 | |
| SCHEMBL1642186 | 0.71 | FASN (0.41) | NAAASMN1; SMN2ALDH1A1FAAHKEAP1 | |
| SCHEMBL475580 | 0.70 | NAAA (0.58) | NAAAFKBP1ANPC1TDP1FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6670447-B2 | An 3-acyl-4-substituted-oxazolidin-2,5-dione that readily reacts with nucleophilic reagents such as free amino acids; use in peptide synthesis for example | MITSUI CHEMICALS, INC. (JP) | 2003-12-30 | — | — | US | disclosed |
| EP-1298127-A1 | AMINO ACID-N-CARBOXY ANHYDRIDES HVAING SUBSTITUENT AT NITROGEN | Mitsui Chemicals, Inc. (JP) | 2003-04-02 | — | — | EP | disclosed |
| CN-1388804-A | Amino acid-N-carboxy anhydrides having substitent at nitrogen | MITSUI CHEMICALS INC (JP) | 2003-01-01 | — | — | CN | disclosed |
| US-20020173664-A1 | Amino acid-n-carboxy anhydrides hvaing substituent at nitrogen | MITSUI CHEMICALS, INC. (JP) | 2002-11-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020173664-A1 | Amino acid-n-carboxy anhydrides hvaing substituent at nitrogen | DNPEP, HDGF, ANPEP | NAAA 53/4885HPGD 187/4885SMN1; SMN2 3873/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.